arrow
M

Maciej Banach

Medical University of Lodz
H指数:142
被引数:18.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Healthcare Professional Awareness and Use of Inflammation-Based Risk Assessment in ASCVD: The CARDIO-INFLAME Survey

医疗专业人员对炎症为基础的风险评估在动脉粥样硬化性心血管疾病中的认知与使用:CARDIO-INFLAME调查

2026-08-290
OAAI
Author Correction: Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trial

作者更正:奥昔特瑞匹在杂合子家族性高胆固醇血症患者中的应用:布鲁克林随机临床试验

2026-04-170
PRE
Mapping the Cognitive Architecture of Health Beliefs: A Multivariate Conditional Network of Perceived Salt-Related Disease Risks

Surma, S.; Lewandowski, Ł.; Momot, K.; Sobierajski, T.; Lewek, J.; Okopień, B.; Banach, M. 绘制健康信念的认知架构:对感知盐相关疾病风险的多元条件网络。Nutrients 2025, 17, 2728. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]

2026-03-030
OAAI
Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trial

Obicetrapib治疗杂合子家族性高胆固醇血症: 布鲁克林随机临床试验

2026-02-270
PRE
Association Between Lipid-Lowering Therapy and Differences in the Distribution of LDL-C, apoB and non-HDL-C

血脂降低疗法与LDL-C、apoB和non-HDL-C分布差异之间的关系

2025-12-200
OAAI
Association Between Metabolic Syndrome Components, Clinical Characteristics, and Telomere Length: Factor Analysis of Mixed Data Based Cluster Analysis of LIPIDOGEN2015 Cross-Sectional Study

代谢综合征组分、临床特征与端粒长度之间的关联:基于LIPIDOGEN2015横断面研究的混合数据因子分析及聚类分析

2025-12-090
OAAI
Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk

奥利泽森(Olezarsen)用于管理严重高甘油三酯血症及胰腺炎风险

2025-11-015
PRE
Association Between Proprotein Convertase Subtilisin/Kexin Type 9 Targeted Therapies And The Risk Of Arrhythmias: A Meta-Analysis Of Randomized Controlled Trials

靶向前蛋白转化酶枯草溶菌素9治疗与心律失常风险之间的关联:一项随机对照试验的荟萃分析

2025-09-210
OAAI